Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
Mikhail Kosiborod, John Eric Deanfield, Richard E. Pratley, Barry A. Borlaug, Javed Butler, Melanie Jane Davies, Scott S. Emerson, Steven E. Kahn, Dalane W. Kitzman, Ildiko Lingvay, Kenneth W. Mahaffey, Mark Colquhoun Petrie, Jorge Plutzky, Søren Rasmussen, Cecilia Rönnbäck, Sanjiv Jayendra Shah, Subodh Verma, Peter Weeke, Abraham Michael Lincoff
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/s0140-6736(24)01643-x
- Published
- Aug 30, 2024
- Venue
- The Lancet
- DOI
- 10.1016/s0140-6736(24)01643-x
- PubMed
- 39222642
- Categories
- Heart Failure Treatment and Management
- Provenance
- openalex